Subscribe
Launches
4 min

How a LinkedIn Post Landed AlchemyPet 60 Doors at Hollywood Feed

AlchemyPet is launching its liquid supplement topper line in 60 Hollywood Feed stores across the Southeast.

Written by
The Underbite
Published on
April 13, 2026
How a LinkedIn Post Landed AlchemyPet 60 Doors at Hollywood Feed

AlchemyPet is launching its microencapsulated liquid supplement line in 60 Hollywood Feed locations across the Southeast.

It's the LA-based brand's first major specialty retail placement, and it didn't come from a trade show booth or a cold email. It came from a LinkedIn post and the kind of introduction that only happens when you're willing to say what you want out loud.

What Happened

AlchemyPet, founded by Colin Topham, will place its five-SKU liquid supplement topper line (anxiety, immunity, joint support, vision, and longevity) in 60 of Hollywood Feed's top-performing stores.

The products use microencapsulation technology, Swiss-engineered and manufactured at an FDA-registered, GMP-certified facility in the US, that the company claims delivers up to 7x greater nutrient absorption than traditional chews, pills, or powders.

Hollywood Feed, the Memphis-based specialty retailer with 175+ stores across 19 states, is led by Shawn McGhee, a former AutoZone EVP who purchased the 1950s-era chain and built it into one of the most respected independent pet retail operations in the country.

The retailer is consistently ranked among the top pet specialty chains by consumers and has carved out a reputation as a trusted voice in premium nutrition.

"Hollywood Feed represents the kind of retail partner we envisioned when we built AlchemyPet," said Colin Topham, CEO and Founder.

"They have spent generations building a legacy of helping pet parents make informed nutritional decisions for their animals. Combining that legacy with our advanced ingredient delivery systems gives us a real opportunity to bring a new standard of effective supplements to more dogs and their owners."

"AlchemyPet stood out in their ability to enable greater nutrient absorption, and we're excited to offer their line in key Hollywood Feed locations," said McGhee.

Why It Matters

Sixty doors at Hollywood Feed is a real milestone for any emerging supplement brand. But how this deal came together is the part worth paying attention to.

Topham had his eye on Hollywood Feed as a retail partner for years. After attending a trade event and not making the connection, he did something simple but specific: he posted about it on LinkedIn. When a commenter asked what he wished he'd gotten done, Topham replied that he'd missed meeting his "dream retailer," and named Hollywood Feed directly.

That post reached Eleanor McGhee, who flagged it to Nikki Usher at Hollywood Feed. From there, the conversations started. Topham and Usher connected, introduced their dogs (and in Usher's case, her chickens and roosters), and over the months that followed, negotiated what became the 60-store launch.

Colin Topham | Founder, Alchemy Pet + Marley

There's a lesson in that for anyone building a brand in this space. Topham didn't put out a vague "looking for retail partners" post. He named the specific company, said why he admired them, and let the network do its thing. It's the kind of move that feels risky in the moment but compounds over time.

If you're a founder trying to break into specialty retail, being visible and specific about who you want to work with can create opportunities that cold outreach and trade show badge scanning never will.

On the product side, the partnership points to growing retailer appetite for supplement format innovation. Microencapsulation has a track record in human nutraceuticals and skincare, but AlchemyPet is one of the first to bring it to pet ingestibles at a retail scale.

Hollywood Feed allocating 60 stores to a first-time brand suggests their buying team liked what they saw in the format and the science behind it.

What to Watch

Hollywood Feed's customer base is built on educated pet parents who already spend more on premium nutrition and wellness. That makes it a strong test market for a liquid supplement format that most consumers haven't encountered before.

The real question is whether those shoppers, who are already comfortable paying up for quality, are ready to shift from chews and powders to a topper format that requires a different routine.

If the format clicks with that audience, it tells the rest of the specialty retail world something important about where pet supplements are heading. Beyond this launch, watch whether microencapsulation starts showing up in other brands' product lines. If it does, that's the signal of a broader format shift in the supplement aisle, not just a single brand bet.

Source: Company press release, AlchemyPet

This news brief is based on a company-submitted announcement. The Underbite verifies claims where possible but cannot independently confirm all details.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
Vetspire Splits From Thrive, Lands a Battery Ventures Backing
Funding & M&A
4 min read

Vetspire Splits From Thrive, Lands a Battery Ventures Backing

Vetspire has spun out of Thrive Pet Healthcare's orbit with a growth investment from Battery Ventures and a new CEO, Zachary Seely. The AI-powered practice management platform, used by more than 800 veterinary hospitals and clinics, will operate independently while Thrive remains a customer. The deal tests whether AI-native vet software can draw institutional capital without a strategic parent underwriting it.

Read article
Read article
PetMeds Revenue Falls 20% as Takeover Fight Drags On
Earnings
6 min read

PetMeds Revenue Falls 20% as Takeover Fight Drags On

PetMeds' first-quarter revenue fell 19.9% to $41.0 million and cash reserves dropped to $13.1 million, even as the company narrowed its net loss to $6.1 million from $34.2 million a year earlier. The results land as an unsolicited $3-a-share buyout offer from SilverCape Investments remains on the table and a $37 million sale-leaseback of its headquarters awaits closing.

Read article
Read article
FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North
Regulatory
4 min read

FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North

The FDA granted Zoetis an emergency use authorization for Simparica Trio to treat New World screwworm in dogs, the first product cleared specifically for the threat. Texas has already begun requiring treatment before dogs cross certain lines, putting boarding facilities, transporters, and border-state vet practices under a new compliance mandate.

Read article
View all articles